FDA Inspection 1302452 — L'Oreal Usa, Inc.

L'Oreal Usa, Inc. — FEI 3003763470

The FDA completed an inspection of L'Oreal Usa, Inc. on April 1, 2026 in Florence, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 1, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Florence, KY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
139621 CFR 211.42(c)(2)Rejected Material Area
150421 CFR 211.122(d)Labels and labeling stored separately